Thomas J. Dougherty

32.6k total citations · 10 hit papers
297 papers, 26.9k citations indexed

About

Thomas J. Dougherty is a scholar working on Pulmonary and Respiratory Medicine, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Thomas J. Dougherty has authored 297 papers receiving a total of 26.9k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Pulmonary and Respiratory Medicine, 95 papers in Materials Chemistry and 87 papers in Molecular Biology. Recurrent topics in Thomas J. Dougherty's work include Photodynamic Therapy Research Studies (161 papers), Porphyrin and Phthalocyanine Chemistry (87 papers) and Nanoplatforms for cancer theranostics (61 papers). Thomas J. Dougherty is often cited by papers focused on Photodynamic Therapy Research Studies (161 papers), Porphyrin and Phthalocyanine Chemistry (87 papers) and Nanoplatforms for cancer theranostics (61 papers). Thomas J. Dougherty collaborates with scholars based in United States, Germany and United Kingdom. Thomas J. Dougherty's co-authors include Barbara W. Henderson, Irvin M. Krieger, Charles J. Gomer, K. R. Weishaupt, Ian J. MacDonald, David Kessel, Qian Peng, G. Jori, Mladen Korbelik and Johan Moan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Thomas J. Dougherty

292 papers receiving 25.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Photodynamic Therapy

1998 4.1k citations Thomas J. Dougherty, Barbara W. Henderson et al. profile →
A Mechanism for Non-Newtonian Flow in Suspensions of Rigid Spheres

1959 2.6k citations Thomas J. Dougherty et al. profile →
HOW DOES PHOTODYNAMIC THERAPY WORK?

1992 2.0k citations Barbara W. Henderson, Thomas J. Dougherty Photochemistry and Photobiology profile →
Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

1976 1.2k citations Thomas J. Dougherty et al. PubMed profile →
Basic principles of photodynamic therapy

2001 1.2k citations Ian J. MacDonald, Thomas J. Dougherty profile →
Photoradiation therapy for the treatment of malignant tumors.

1978 1.2k citations Thomas J. Dougherty et al. PubMed profile →
Ceramic-Based Nanoparticles Entrapping Water-Insoluble Photosensitizing Anticancer Drugs: A Novel Drug−Carrier System for Photodynamic Therapy

2003 707 citations Allan R. Oseroff, Thomas J. Dougherty et al. profile →
PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS

1987 655 citations Thomas J. Dougherty Photochemistry and Photobiology profile →
Photoradiation Therapy. II. Cure of Animal Tumors With Hematoporphyrin and Light23

1975 534 citations Thomas J. Dougherty et al. profile →
Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.

1979 419 citations Thomas J. Dougherty et al. PubMed profile →

Peers

Countries citing papers authored by Thomas J. Dougherty

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Dougherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Dougherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Dougherty more than expected).

Fields of papers citing papers by Thomas J. Dougherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Dougherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Dougherty. The network helps show where Thomas J. Dougherty may publish in the future.

Co-authorship network of co-authors of Thomas J. Dougherty

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Dougherty. A scholar is included among the top collaborators of Thomas J. Dougherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Dougherty. Thomas J. Dougherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of Substance Abuse Among Trauma Patients in Rural West Virginia 2023 ·Cureus ·(unknown), (unknown), Hari Vishal Lakhani, (unknown), Sharon E. Jones, Komal Sodhi, Ellen Thompson, Thomas J. Dougherty	2
2	Rare case of metaplastic breast cancer in a man 2018 ·BMJ Case Reports ·(unknown), (unknown), Thomas J. Dougherty, (unknown)	2
3	Target-Based Resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a Novel Bacterial Type II Topoisomerase Inhibitor 2014 ·Antimicrobial Agents and Chemotherapy ·Asha S. Nayar, Thomas J. Dougherty, Folkert Reck, Jason Thresher, Ning Gao, Adam B. Shapiro, David E. Ehmann	21
4	Identification of an Inhibitor of the MurC Enzyme, Which Catalyzes an Essential Step in the Peptidoglycan Precursor Synthesis Pathway 2008 ·Assay and Drug Development Technologies ·Laura E. Zawadzke, (unknown), Charlene Desbonnet, Hong Wang, Kevin D. Freeman‐Cook, Thomas J. Dougherty	18
5	A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin®) for treatment of basal cell carcinoma 2006 ·Lasers in Surgery and Medicine ·Allan R. Oseroff, (unknown), B. Dale Wilson, Thomas S. Mang, David A. Bellnier, John Carmi Parsons, (unknown), Michele Cooper, Nathalie C. Zeitouni, Thomas J. Dougherty	39
6	Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy 2005 ·Cancer Chemotherapy and Pharmacology ·David A. Bellnier, William R. Greco, Hector Nava, Gregory Loewen, Allan R. Oseroff, Thomas J. Dougherty	88
7	Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. 2003 ·PubMed ·David A. Bellnier, William R. Greco, Gregory Loewen, Hector Nava, Allan R. Oseroff, Ravindra K. Pandey, Takaaki Tsuchida, Thomas J. Dougherty	112
8	2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy 2001 ·Lasers in Surgery and Medicine ·Jeffrey S. Lobel, Ian J. MacDonald, Michael J. Ciesielski, Tara A. Barone, William R. Potter, John Pollina, Robert J. Plunkett, Robert A. Fenstermaker, Thomas J. Dougherty	51
9	Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy 1999 ·Investigational New Drugs ·Charles J. Dimitroff, Wayne D. Klohs, Amarnath Sharma, Paula Pera, Denise L. Driscoll, Jean Veith, Randall W. Steinkampf, Mel C. Schroeder, S. KLUTCHKO, Adam B. Sumlin, Barbara W. Henderson, Thomas J. Dougherty, Ralph J. Bernacki	71
10	Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi‚s sarcoma 1999 ·AIDS ·Zale P. Bernstein, B. Dale Wilson, Allan R. Oseroff, (unknown), (unknown), John S. Brooks, Richard Cheney, (unknown), Thomas S. Mang, David A. Bellnier, Thomas J. Dougherty	28
11	Foreword 1995 ·Seminars in Surgical Oncology ·Thomas J. Dougherty	9
12	Flow instability in vertical upflow under low heat flux conditions 1993 ·Transactions of the American Nuclear Society ·(unknown), Thomas J. Dougherty, (unknown), Edward V. McAssey, (unknown)	2
13	ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF PHOTOFRIN® 1991 ·Photochemistry and Photobiology ·Yau‐Kwan Ho, Joseph R. Missert, Thomas J. Dougherty	7
14	Porphyrin dimers as photosensitizers in photodynamic therapy 1990 ·Journal of Medicinal Chemistry ·Ravindra K. Pandey, Kevin M. Smith, Thomas J. Dougherty	82
15	Haematoporphyrin Derivative Photosensitization and γ-radiation Damage Interaction in Chinese Hamster Ovary Fibroblasts 1986 ·International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine ·David A. Bellnier, Thomas J. Dougherty	26
16	Photodynamic Therapy 1985 ·Advances in experimental medicine and biology ·Thomas J. Dougherty	39
17	Cancer treatment with laser irradiation and tumor-seeking photosensitizers (A) 1984 ·Journal of the Optical Society of America B ·Thomas J. Dougherty	2
18	Synthesis and modification of the peptidoglycan inNeisseria gonorrhoeae 1983 ·FEMS Microbiology Letters ·Thomas J. Dougherty	15
19	Lasers and hematoporphyrin derivative in cancer 1983 ·(unknown), Thomas J. Dougherty	58
20	Photoradiation Therapy for Cutaneous and Subcutaneous Malignancies 1981 ·Journal of Investigative Dermatology ·Thomas J. Dougherty	138

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact